Aristotle University Of Thessaloniki (AUTH)
Μοριακή ανάλυση του μεταγραφώματος των ριβοσωμάτων κατά την ερυθροποίηση και -ομική προσέγγιση για τη φαρμακολογική αξιοποίηση στις ριβοσωμοπάθειες
Abstract
dc:descriptionErythropoiesis remains a complex biological process with several unresolved aspects, particularly regarding the molecular transitions that accompany its progression. A deeper understanding of the mechanisms connected with erythroid differentiation could contribute to the development of novel therapeutic targets for related pathologies. This dissertation investigates the transcriptomic landscape of MEL cells, an established cellular model of erythropoiesis with the aim of identifying genes that may serve as potential drug targets. During differentiation induced by HMBA, activation of signaling pathways associated with cell-cycle arrest and hemoglobin synthesis was confirmed, reflecting the transition toward a mature erythrocyte phenotype. Comprehensive analysis of Ribosome-Associated Proteins (RAPs) at both the proteomic and transcriptomic levels revealed an up-regulation of RAPs implicated in heme biosynthesis and a down-regulation of RAPs involved in rRNA processing and ribosome biogenesis. STEAP3 was selected to be furtherly explored as a potential RAP. Prior to differentiation, STEAP3 was detected within monosomes (80S) and free ribosomal subunits (40S, 60S), while it was absent in polysomes. Post induction, STEAP3 was no longer present in any ribosomal fraction. Furthermore, immunoprecipitation assays demonstrated an interaction between STEAP3 and translation-associated factors (e.g., EIF3a), suggesting a new role for STEAP3 as a regulator of translational activity. Moreover, silencing of the Steap3 gene in MEL cells caused extensive remodeling of both transcriptomic and proteomic profiles, including the activation of multiple erythroid markers, the induction of several ferroptosis-promoting factors, and a decrease in several ferroptosis inhibitors. In parallel, the effect of compound 001, an antagonistic molecule targeting STEAP3, was examined. Its action recapitulated the effects of Steap3 silencing. Although the level of response varied among the markers analyzed, compound 001 consistently induced a notable increase in β-globin expression at both the transcript and protein levels. This observation suggests that compound 001 may facilitate the onset of erythroid differentiation and represents a promising lead for further investigation. Moreover, ferroptosis markers were evaluated during HMBA-induced differentiation of MEL cells. The observed up-regulation of ferroptosis inducers and down-regulation of inhibitors support the notion that ferroptosis may constitute a physiological, concomitant mechanism of erythropoiesis. This hypothesis was further tested through treatment with erastin, a well-known ferroptosis inducer, which led to a modest increase in erythroid markers; however, its pronounced cytotoxic stress appeared to outweigh any differentiating potential. Collectively, this work characterizes STEAP3 as an enzyme with a multifactional role in erythropoiesis, influencing translational control, ribosome biogenesis, and ferroptotic signaling. At the same time, compound 001 emerges as a promising pharmacological candidate. These findings provide new insights for the development of targeted therapeutic strategies in disorders of erythropoiesis.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papadimitriou-Tsantarliotou, Aliki
- Παπαδημητρίου-Τσανταρλιώτου, Αλίκη
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60188